← All sarcoma trials
Recruiting nowAges 18 Years and up

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

Sponsor: Washington University School of Medicine · NCT04354064 on ClinicalTrials.gov ↗

Conditions studied

Healthy VolunteerProstate CancerHead and Neck CancerEsophageal CancerGenitourinary CancerSarcomaBreast CancerColon CancerGastrointestinal CancerSolid Tumor CancerLung CancerSkin CancerMelanoma

Where it's running1 site

  • Washington University School of Medicine

    St Louis, Missouri 63110

    Recruiting now
    • Melissa Reimers, M.D.(contact)314-362-7249[email protected]
    • Melissa Reimers, M.D.(principal investigator)
    • Peter Harris, Ph.D.(sub investigator)
    • Re-I Chin, M.D.(sub investigator)
    • Hiram Gay, M.D.(sub investigator)
    • Wade Thorstad, M.D.(sub investigator)
    • Jose Zevallos, M.D., MPH(sub investigator)
    • Sidharth Puram, M.D., Ph.D.(sub investigator)
    • Varun Puri, M.D.(sub investigator)
    • Christopher Maher, Ph.D.(sub investigator)
    • Ha Dang, Ph.D.(sub investigator)
    • Paul Jones, B.A.(sub investigator)
    • Benjamin Tan, M.D.(sub investigator)
    • Zachary Smith, M.D.(sub investigator)
    • Eric Kim, M.D.(sub investigator)
    • Vivek Arora, M.D.(sub investigator)
    • Brian Van Tine, M.D., Ph.D.(sub investigator)
    • Angela Hirbe, M.D., Ph.D.(sub investigator)
    • Cynthia Ma, M.D., Ph.D.(sub investigator)
    • Imran Zoberi, M.D.(sub investigator)
    • Ryan Fields, M.D.(sub investigator)
    • Koushik Das, M.D.(sub investigator)
    • Ricardo Ramirez, M.D.(sub investigator)
    • David Chen, M.D., Ph.D.(sub investigator)
    • Nicholas Semenkovich, M.D., Ph.D.(sub investigator)
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Eligible healthy donors will be at least 18 years of age.

Exclusion Criteria:

* Healthy donors younger than 18 years of age

Updated 2026-02-20 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.